iShares U.S. Pharmaceuticals ETF (IHE) Chart & Stock Price History → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free IHE Stock Alerts $63.31 +0.58 (+0.92%) (As of 04/26/2024 ET) Add Compare Share Share ChartStock AnalysisChartHeadlinesHoldingsOwnershipRatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatings iShares U.S. Pharmaceuticals ETF Stock Price Performance5 Day Performance+0.11%1 Month Performance-6.48%3 Month Performance-0.90%6 Month Performance+13.99%Year-To-Date Performance+2.44%1 Year Performance+5.55% Receive IHE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iShares U.S. Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the MarketsWhy Big Pharma is Investing Billions in This BiotechIf you're on the hunt for a great biotech stock under $20... you need to see this video.Watch my exclusive report here>>> IHE Stock Chart for Saturday, April, 27, 2024 IHE Chart by TradingView iShares U.S. Pharmaceuticals ETF Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/26/2024$62.85$63.31+0.73%$63.47$62.7123,808 shs$639.43 million04/25/2024$63.52$62.85-1.05%$63.28$62.68316,888 shs$634.79 million04/24/2024$63.92$63.52-0.63%$63.93$63.2413,267 shs$641.55 million04/23/2024$63.24$63.92+1.08%$64.08$63.5416,032 shs$645.59 million04/22/2024$63.02$63.24+0.35%$63.73$63.0725,123 shs$638.72 million04/19/2024$63.10$62.99-0.17%$63.21$62.7867,633 shs$129.13 million Get the Latest News and Ratings for IHE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for iShares U.S. Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter. 04/18/2024$63.21$63.10-0.17%$63.32$62.8820,218 shs$129.36 million04/17/2024$63.32$63.21-0.17%$63.74$63.12236,663 shs$129.58 million04/16/2024$63.57$63.32-0.39%$63.66$63.2740,954 shs$129.81 million04/15/2024$63.69$63.57-0.19%$64.52$63.4824,164 shs$130.32 million04/12/2024$64.95$63.69-1.94%$64.69$63.62288,439 shs$130.56 million04/11/2024$65.23$64.95-0.43%$65.41$64.7015,067 shs$133.15 million04/10/2024$65.84$65.23-0.93%$65.49$65.0623,987 shs$133.72 million04/09/2024$65.99$65.84-0.23%$66.04$65.5317,734 shs$134.97 million04/08/2024$66.33$65.99-0.51%$66.35$65.9915,213 shs$135.28 million04/05/2024$65.90$66.33+0.65%$66.43$65.7914,825 shs$135.98 million04/04/2024$66.60$65.90-1.05%$66.99$65.9028,351 shs$135.10 million04/03/2024$66.83$66.60-0.34%$67.23$66.44252,072 shs$136.53 million04/02/2024$67.11$66.83-0.42%$66.83$66.38571,654 shs$137.00 million04/01/2024$67.90$67.11-1.16%$67.83$66.8625,156 shs$137.58 million03/29/2024$67.90$67.90$68.25$67.8732,695 shs$139.19 million03/28/2024$67.70$67.90+0.29%$68.25$67.8732,695 shs$139.19 million03/27/2024$66.71$67.70+1.48%$67.71$67.0841,319 shs$138.79 million03/26/2024$66.72$66.71-0.02%$66.86$66.5925,676 shs$136.76 million03/25/2024$66.67$66.72+0.07%$67.15$66.7276,794 shs$136.78 million03/22/2024$67.17$66.67-0.74%$67.46$66.67234,925 shs$136.67 million03/21/2024$67.36$67.17-0.28%$67.50$67.1616,104 shs$137.70 million03/20/2024$67.14$67.36+0.33%$67.45$66.8327,897 shs$138.09 million03/19/2024$66.77$67.14+0.55%$67.17$66.5120,810 shs$137.64 million03/18/2024$67.01$66.77-0.36%$67.18$66.7727,896 shs$136.88 million03/15/2024$67.08$67.01-0.10%$67.01$66.6646,013 shs$137.37 million03/14/2024$67.50$67.08-0.62%$67.79$66.7518,962 shs$137.51 million03/13/2024$67.61$67.50-0.16%$67.78$67.4013,829 shs$138.38 million03/12/2024$67.09$67.61+0.78%$67.69$67.0534,437 shs$138.60 million03/11/2024$67.75$67.09-0.97%$67.57$66.7325,567 shs$137.53 million03/08/2024$68.02$67.74-0.41%$68.04$67.6217,505 shs$138.87 million03/07/2024$67.88$68.02+0.20%$68.42$67.5228,029 shs$139.44 million03/06/2024$67.80$67.88+0.13%$68.31$67.77147,660 shs$417.48 million03/05/2024$68.24$67.80-0.65%$68.25$67.5769,972 shs$416.96 million03/04/2024$68.77$68.24-0.77%$69.17$68.1049,167 shs$419.69 millionWhy Big Pharma is Investing Billions in This Biotech (Ad)If you're on the hunt for a great biotech stock under $20... you need to see this video.Watch my exclusive report here>>>03/01/2024$67.86$68.77+1.34%$68.77$68.07325,731 shs$422.94 million02/29/2024$68.55$67.86-1.01%$68.19$67.8627,318 shs$417.36 million02/28/2024$69.27$68.55-1.03%$69.34$68.4542,084 shs$421.60 million02/27/2024$69.36$69.27-0.14%$69.38$69.1821,123 shs$425.99 million02/26/2024$69.55$69.36-0.27%$69.53$69.3318,123 shs$426.58 million02/23/2024$69.10$69.55+0.64%$69.56$69.1133,693 shs$427.72 million02/22/2024$68.09$69.10+1.48%$69.11$68.4732,538 shs$424.99 million02/21/2024$68.24$68.09-0.22%$68.09$67.6721,030 shs$418.77 million02/20/2024$68.97$68.24-1.05%$69.12$68.1848,477 shs$419.70 million02/19/2024$68.97$68.97$69.39$68.36138,300 shs$424.15 million02/16/2024$68.43$69.06+0.92%$69.39$68.36138,567 shs$424.74 million02/15/2024$67.20$68.43+1.83%$68.46$67.67474,066 shs$420.86 million02/14/2024$66.52$67.20+1.02%$67.20$66.8924,486 shs$413.28 million02/13/2024$67.43$66.52-1.36%$66.99$66.2935,931 shs$409.10 million02/12/2024$66.96$67.43+0.71%$67.50$67.0441,142 shs$414.72 million02/09/2024$66.46$66.96+0.75%$67.01$66.6925,272 shs$411.80 million02/08/2024$66.29$66.46+0.25%$66.46$66.1683,403 shs$408.72 million02/07/2024$66.32$66.29-0.05%$66.63$66.2694,218 shs$407.68 million02/06/2024$65.28$66.32+1.59%$66.32$65.8784,645 shs$407.87 million02/05/2024$64.34$65.28+1.47%$65.35$64.8826,274 shs$401.49 million02/02/2024$64.47$64.34-0.20%$64.63$63.87132,771 shs$395.69 million02/01/2024$63.73$64.47+1.15%$64.47$63.6026,505 shs$396.47 million01/31/2024$64.08$63.73-0.54%$64.60$63.6562,835 shs$391.96 million01/30/2024$64.51$64.08-0.67%$64.38$63.9152,743 shs$394.09 million01/29/2024$63.88$64.51+0.99%$64.51$63.8341,574 shs$396.76 million01/26/2024$63.41$63.88+0.74%$64.05$63.7482,005 shs$392.88 million Related Companies: PPH Stock Chart IHF Stock Chart BBH Stock Chart LABU Stock Chart RSPH Stock Chart XHE Stock Chart PJP Stock Chart PBE Stock Chart PSCH Stock Chart XPH Stock Chart Receive IHE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for iShares U.S. Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEARCA:IHE) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyProtect Your Bank Account Before It’s Too LateWeiss RatingsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares U.S. Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.